CompletedNANCT07194317

A Feasibility Study to Determine the Most Appropriate Digital Dietary Assessment Tool in Patients With Obesity Initiating GLP-1 Receptor Agonist Treatment

Sponsor: King's College London

Trial Details

ConditionObese Patients
InterventionTesting 3 different digital dietary assessment tools in a random order (Nutritics-Libro, MyFood24 and Intake24)
PhaseNA
StatusCompleted
Participants64
Est. Completion13 Mar 2026
Last Updated29 May 2026

Primary Outcome

Usability; Usability and context of use

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Adults aged \>18 years * Living with obesity as diagnosed by healthcare professional. * Referral to T3WMS at GSTT and currently on the service waiting list * Eligible for GLP-1 receptor agonist (Wegovy) prescription * Have an active MyChart account * Have an email address * Access to a digital device such as a smart phone, computer or tablet where you can access the internet * Not following a meal replacement diet, for example soups / shakes * Able to provide informed consent. * Able to complete surveys in English. Exclusion Criteria: * Adults aged \>18 years * Living with obesity as diagnosed by healthcare professional. * Referral to T3WMS at GSTT and currently on the service waiting list * Eligible for GLP-1 receptor agonist (Wegovy) prescription * Have an active MyChart account * Have an email address * Access to a digital device such as a smart phone, computer or tablet where you can access the internet * Not following a meal replacement diet, for example soups / shakes * Able to provide informed consent. * Able to complete surveys in English. * Not able to provide informed consent * Not able to complete surveys in English * Has an eating disorder * Taking part in another research trial that involves dietary modification

Trial Sites

Countries

United Kingdom
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service